(Q53085995)

11 May 2018

title

Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. (English)

1 reference

11 May 2018

1 reference

0 references

7

Yair Lotan

1 reference

11 May 2018

8

Pierre I Karakiewicz

1 reference

11 May 2018

Maxine Sun

9

Maxine Sun

1 reference

11 May 2018

Shahrokh Shariat

14

Shahrokh F Shariat

1 reference

11 May 2018

Luis A Kluth

3

Luis Kluth

1 reference

11 May 2018

Harun Fajkovic

10

Harun Fajkovic

1 reference

11 May 2018

Evanguelos Xylinas

2

Evanguelos Xylinas

1 reference

11 May 2018

Malte Rieken

1

Malte Rieken

1 reference

11 May 2018

Joseph J Crivelli

4

Joseph J Crivelli

1 reference

11 May 2018

Talia Faison

6

Talia Faison

1 reference

11 May 2018

Marek Babjuk

11

Marek Babjuk

1 reference

11 May 2018

author name string

James Chrystal

5

1 reference

11 May 2018

Alexander Bachmann

12

1 reference

11 May 2018

Douglas S Scherr

13

1 reference

11 May 2018

publication date

17 October 2013

1 reference

11 May 2018

published in

Urologic Oncology

1 reference

11 May 2018

volume

32

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

49.e7-14

1 reference

11 May 2018

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Diabetes mellitus and risk of bladder cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Diabetes and risk of bladder cancer: evidence from a case-control study in New England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Diabetes worsens the surgical outcomes in cirrhotic patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Effect of diabetes on endometrial cancer recurrence and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Metformin and reduced risk of cancer in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Metformin: taking away the candy for cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Pioglitazone and bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via PI3K-independent activation of Akt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.07.006

10.1016/J.UROLONC.2013.07.006

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

24140245

1 reference

11 May 2018